EASTMAN CHEMICAL CO (EMN) Fundamental Analysis & Valuation

NYSE:EMN • US2774321002

Current stock price

71.59 USD
-0.52 (-0.72%)
Last:

This EMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. EMN Profitability Analysis

1.1 Basic Checks

  • EMN had positive earnings in the past year.
  • EMN had a positive operating cash flow in the past year.
  • In the past 5 years EMN has always been profitable.
  • Each year in the past 5 years EMN had a positive operating cash flow.
EMN Yearly Net Income VS EBIT VS OCF VS FCFEMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • EMN's Return On Assets of 3.19% is fine compared to the rest of the industry. EMN outperforms 71.95% of its industry peers.
  • The Return On Equity of EMN (7.95%) is better than 74.39% of its industry peers.
  • The Return On Invested Capital of EMN (6.13%) is better than 67.07% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for EMN is in line with the industry average of 6.49%.
Industry RankSector Rank
ROA 3.19%
ROE 7.95%
ROIC 6.13%
ROA(3y)5.08%
ROA(5y)5.24%
ROE(3y)13.33%
ROE(5y)14.08%
ROIC(3y)7.13%
ROIC(5y)8.47%
EMN Yearly ROA, ROE, ROICEMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • The Profit Margin of EMN (5.42%) is better than 74.39% of its industry peers.
  • EMN's Profit Margin has been stable in the last couple of years.
  • The Operating Margin of EMN (10.56%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of EMN has declined.
  • EMN's Gross Margin of 21.09% is in line compared to the rest of the industry. EMN outperforms 40.24% of its industry peers.
  • In the last couple of years the Gross Margin of EMN has declined.
Industry RankSector Rank
OM 10.56%
PM (TTM) 5.42%
GM 21.09%
OM growth 3Y-5.12%
OM growth 5Y-2.29%
PM growth 3Y-10.27%
PM growth 5Y-0.81%
GM growth 3Y1.45%
GM growth 5Y-1.98%
EMN Yearly Profit, Operating, Gross MarginsEMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

4

2. EMN Health Analysis

2.1 Basic Checks

  • EMN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for EMN has been reduced compared to 1 year ago.
  • The number of shares outstanding for EMN has been reduced compared to 5 years ago.
  • EMN has a better debt/assets ratio than last year.
EMN Yearly Shares OutstandingEMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
EMN Yearly Total Debt VS Total AssetsEMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.38 indicates that EMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of EMN (2.38) is better than 62.20% of its industry peers.
  • The Debt to FCF ratio of EMN is 11.29, which is on the high side as it means it would take EMN, 11.29 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 11.29, EMN is in line with its industry, outperforming 56.10% of the companies in the same industry.
  • EMN has a Debt/Equity ratio of 0.70. This is a neutral value indicating EMN is somewhat dependend on debt financing.
  • The Debt to Equity ratio of EMN (0.70) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 11.29
Altman-Z 2.38
ROIC/WACC0.54
WACC11.3%
EMN Yearly LT Debt VS Equity VS FCFEMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • EMN has a Current Ratio of 1.37. This is a normal value and indicates that EMN is financially healthy and should not expect problems in meeting its short term obligations.
  • EMN has a Current ratio of 1.37. This is in the lower half of the industry: EMN underperforms 73.17% of its industry peers.
  • EMN has a Quick Ratio of 1.37. This is a bad value and indicates that EMN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.63, EMN is not doing good in the industry: 89.02% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.63
EMN Yearly Current Assets VS Current LiabilitesEMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

4

3. EMN Growth Analysis

3.1 Past

  • EMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.56%.
  • EMN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.54% yearly.
  • The Revenue has decreased by -6.71% in the past year.
  • The Revenue has been growing slightly by 0.65% on average over the past years.
EPS 1Y (TTM)-31.56%
EPS 3Y-11.65%
EPS 5Y-2.54%
EPS Q2Q%-59.89%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y-6.13%
Revenue growth 5Y0.65%
Sales Q2Q%-12.12%

3.2 Future

  • Based on estimates for the next years, EMN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.84% on average per year.
  • The Revenue is expected to grow by 1.77% on average over the next years.
EPS Next Y11.23%
EPS Next 2Y12.85%
EPS Next 3Y12.77%
EPS Next 5Y14.84%
Revenue Next Year1.58%
Revenue Next 2Y2.52%
Revenue Next 3Y2.73%
Revenue Next 5Y1.77%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EMN Yearly Revenue VS EstimatesEMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
EMN Yearly EPS VS EstimatesEMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

6

4. EMN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 13.26, which indicates a correct valuation of EMN.
  • Based on the Price/Earnings ratio, EMN is valued cheaper than 84.15% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of EMN to the average of the S&P500 Index (27.15), we can say EMN is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 11.92, the valuation of EMN can be described as reasonable.
  • EMN's Price/Forward Earnings ratio is rather cheap when compared to the industry. EMN is cheaper than 84.15% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.12, EMN is valued a bit cheaper.
Industry RankSector Rank
PE 13.26
Fwd PE 11.92
EMN Price Earnings VS Forward Price EarningsEMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EMN indicates a somewhat cheap valuation: EMN is cheaper than 74.39% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMN indicates a somewhat cheap valuation: EMN is cheaper than 74.39% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.31
EV/EBITDA 8.68
EMN Per share dataEMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as EMN's earnings are expected to grow with 12.77% in the coming years.
PEG (NY)1.18
PEG (5Y)N/A
EPS Next 2Y12.85%
EPS Next 3Y12.77%

8

5. EMN Dividend Analysis

5.1 Amount

  • EMN has a Yearly Dividend Yield of 4.67%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.00, EMN pays a better dividend. On top of this EMN pays more dividend than 91.46% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, EMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.67%

5.2 History

  • The dividend of EMN has a limited annual growth rate of 4.78%.
  • EMN has paid a dividend for at least 10 years, which is a reliable track record.
  • EMN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.78%
Div Incr Years16
Div Non Decr Years31
EMN Yearly Dividends per shareEMN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • EMN pays out 80.38% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of EMN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP80.38%
EPS Next 2Y12.85%
EPS Next 3Y12.77%
EMN Yearly Income VS Free CF VS DividendEMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
EMN Dividend Payout.EMN Dividend Payout, showing the Payout Ratio.EMN Dividend Payout.PayoutRetained Earnings

EMN Fundamentals: All Metrics, Ratios and Statistics

EASTMAN CHEMICAL CO

NYSE:EMN (4/28/2026, 2:30:04 PM)

71.59

-0.52 (-0.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-29
Earnings (Next)04-30
Inst Owners91.81%
Inst Owner Change-0.02%
Ins Owners0.83%
Ins Owner Change6.86%
Market Cap8.19B
Revenue(TTM)8.75B
Net Income(TTM)474.00M
Analysts76.36
Price Target79.17 (10.59%)
Short Float %4.52%
Short Ratio3.34
Dividend
Industry RankSector Rank
Dividend Yield 4.67%
Yearly Dividend3.33
Dividend Growth(5Y)4.78%
DP80.38%
Div Incr Years16
Div Non Decr Years31
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.02%
Min EPS beat(2)-3.04%
Max EPS beat(2)3.07%
EPS beat(4)1
Avg EPS beat(4)-2.08%
Min EPS beat(4)-8.32%
Max EPS beat(4)3.07%
EPS beat(8)5
Avg EPS beat(8)3.91%
EPS beat(12)9
Avg EPS beat(12)5.28%
EPS beat(16)11
Avg EPS beat(16)2.19%
Revenue beat(2)0
Avg Revenue beat(2)-3.37%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)-3.24%
Revenue beat(4)0
Avg Revenue beat(4)-2.73%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)-1.63%
Revenue beat(8)1
Avg Revenue beat(8)-1.44%
Revenue beat(12)1
Avg Revenue beat(12)-2.45%
Revenue beat(16)3
Avg Revenue beat(16)-1.36%
PT rev (1m)2.05%
PT rev (3m)6.38%
EPS NQ rev (1m)-2.48%
EPS NQ rev (3m)-14.71%
EPS NY rev (1m)1.83%
EPS NY rev (3m)-2.55%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-0.45%
Revenue NY rev (1m)1.13%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 13.26
Fwd PE 11.92
P/S 0.94
P/FCF 19.31
P/OCF 8.44
P/B 1.37
P/tB 6.17
EV/EBITDA 8.68
EPS(TTM)5.4
EY7.54%
EPS(NY)6.01
Fwd EY8.39%
FCF(TTM)3.71
FCFY5.18%
OCF(TTM)8.48
OCFY11.85%
SpS76.54
BVpS52.13
TBVpS11.6
PEG (NY)1.18
PEG (5Y)N/A
Graham Number79.5847 (11.17%)
Profitability
Industry RankSector Rank
ROA 3.19%
ROE 7.95%
ROCE 7.57%
ROIC 6.13%
ROICexc 6.43%
ROICexgc 10.69%
OM 10.56%
PM (TTM) 5.42%
GM 21.09%
FCFM 4.84%
ROA(3y)5.08%
ROA(5y)5.24%
ROE(3y)13.33%
ROE(5y)14.08%
ROIC(3y)7.13%
ROIC(5y)8.47%
ROICexc(3y)7.54%
ROICexc(5y)8.89%
ROICexgc(3y)12.66%
ROICexgc(5y)15.23%
ROCE(3y)8.8%
ROCE(5y)10.46%
ROICexgc growth 3Y-15.19%
ROICexgc growth 5Y-0.92%
ROICexc growth 3Y-12.8%
ROICexc growth 5Y1.35%
OM growth 3Y-5.12%
OM growth 5Y-2.29%
PM growth 3Y-10.27%
PM growth 5Y-0.81%
GM growth 3Y1.45%
GM growth 5Y-1.98%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 11.29
Debt/EBITDA 2.92
Cap/Depr 106.43%
Cap/Sales 6.24%
Interest Coverage 4.3
Cash Conversion 67.5%
Profit Quality 89.45%
Current Ratio 1.37
Quick Ratio 0.63
Altman-Z 2.38
F-Score5
WACC11.3%
ROIC/WACC0.54
Cap/Depr(3y)130.13%
Cap/Depr(5y)124.87%
Cap/Sales(3y)7.2%
Cap/Sales(5y)6.56%
Profit Quality(3y)75.52%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)-31.56%
EPS 3Y-11.65%
EPS 5Y-2.54%
EPS Q2Q%-59.89%
EPS Next Y11.23%
EPS Next 2Y12.85%
EPS Next 3Y12.77%
EPS Next 5Y14.84%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y-6.13%
Revenue growth 5Y0.65%
Sales Q2Q%-12.12%
Revenue Next Year1.58%
Revenue Next 2Y2.52%
Revenue Next 3Y2.73%
Revenue Next 5Y1.77%
EBIT growth 1Y-31.04%
EBIT growth 3Y-10.93%
EBIT growth 5Y-1.66%
EBIT Next Year61.16%
EBIT Next 3Y22.95%
EBIT Next 5Y20.52%
FCF growth 1Y-38.37%
FCF growth 3Y6.5%
FCF growth 5Y-16.93%
OCF growth 1Y-24.63%
OCF growth 3Y-0.17%
OCF growth 5Y-7.79%

EASTMAN CHEMICAL CO / EMN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EASTMAN CHEMICAL CO?

ChartMill assigns a fundamental rating of 5 / 10 to EMN.


Can you provide the valuation status for EASTMAN CHEMICAL CO?

ChartMill assigns a valuation rating of 6 / 10 to EASTMAN CHEMICAL CO (EMN). This can be considered as Fairly Valued.


How profitable is EASTMAN CHEMICAL CO (EMN) stock?

EASTMAN CHEMICAL CO (EMN) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for EMN stock?

The Price/Earnings (PE) ratio for EASTMAN CHEMICAL CO (EMN) is 13.26 and the Price/Book (PB) ratio is 1.37.


What is the financial health of EASTMAN CHEMICAL CO (EMN) stock?

The financial health rating of EASTMAN CHEMICAL CO (EMN) is 4 / 10.